Letko, Brosseau & Associates’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-17,800
Closed -$28K 102
2022
Q3
$28K Hold
17,800
﹤0.01% 101
2022
Q2
$32K Hold
17,800
﹤0.01% 100
2022
Q1
$56K Hold
17,800
﹤0.01% 101
2021
Q4
$54K Hold
17,800
﹤0.01% 107
2021
Q3
$111K Hold
17,800
﹤0.01% 105
2021
Q2
$152K Hold
17,800
﹤0.01% 106
2021
Q1
$273K Hold
17,800
﹤0.01% 101
2020
Q4
$287K Hold
17,800
﹤0.01% 101
2020
Q3
$249K Buy
+17,800
New +$265K ﹤0.01% 95

Other funds holding BCEL

Letko, Brosseau & Associates's BCEL Position: Q4 2022 in Review

Letko, Brosseau & Associates sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q4 2022, closing a stake of 17,800 shares — an estimated $28K sold.

Letko, Brosseau & Associates first reported a position in BCEL in Q3 2020 and held it in 9 quarters. The position peaked at $287K in Q4 2020. 58 funds tracked by Wall St. Rank hold BCEL as of Q4 2022.

  • Letko, Brosseau & Associates reported no remaining Atreca, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 17,800 Atreca, Inc. Class A Common Stock shares in Q4 2022, an estimated $28K.
  • Letko, Brosseau & Associates first reported a position in Atreca, Inc. Class A Common Stock in Q3 2020 and held it in 9 quarters.
  • Letko, Brosseau & Associates's Atreca, Inc. Class A Common Stock position peaked at $287K in Q4 2020.
  • 58 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q4 2022.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2022, filed 10 Feb 2023.